WHITEPAPER - From Service Provider to Strategic Partner
By: Tom Sellig, CEO, Adare Pharma Solutions
As drug development grows more complex and timelines compress, sponsors require CDMO relationships built on integration, flexibility, and shared accountability. The relationship between pharmaceutical sponsors and their CDMO partners has undergone a fundamental transformation. Not long ago, CDMOs were largely treated as capacity providers that executed a defined scope, then stepped aside. Today, the most successful partnerships look nothing like that. They are deeply embedded collaborations in which both parties are genuinely invested in outcomes, from early formulation through commercial launch and beyond.
Total Page Views: 131
